Bigul

Fabino Life Sciences Ltd - 543444 - Reg. 34 (1) Annual Report.

Annual Report under Reg 34 of SEBI (LODR) Regulations, 2015.
18-08-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Intimation Of Book Closure For 12Th Annual General Meeting

Intimation of Book Closure for 12th AGM to be held on September 12, 2023.
18-08-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Announcement under Regulation 30 (LODR)-Acquisition

Announcement under Regulation 30 (LODR) - Acquisition
31-07-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

Please find enclosed disclosure under Regulation 30 (LODR) for Change in Registered Office of the Company.
29-07-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May, 2023.

In continuation of our letter dated May 17, 2023, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held on 30th May 2023, inter alia considered and approved as attched.
30-05-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Outcome Of Board Meeting Held On 30Th May, 2023.

In continuation of our letter dated May 17, 2023, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held on 30th May 2023, inter alia considered and approved as attached.
30-05-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Board Meeting Intimation for Adjournment Of Outcome Of Board Meeting Scheduled On 24Th May, 2023

Fabino Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve In continuation of our letter dated May 17, 2023, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting scheduled to be held on 24th May, now stands adjourned due to non-availability of Directors and the meeting will now be held on Tuesday, May 30, 2023 at Registered Office of the Company at 105, Plot No 12, Barodia Tower, 1st Floor, D Block, Central Market, Prashant Vihar, New Delhi- 110085, inter-alia to discuss and approve, among other items, the Audited Financial Results and Statement of Assets and Liabilities for Half Year and Financial Year ended March 31, 2023
24-05-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Board Meeting Intimation for Intimation Of Board Meeting For Consideration And Approval Of Audited Financial Results For Half Year And Financial Year Ended March 31, 2023

Fabino Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve In pursuant to Regulation 29(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 this is to inform you, that a meeting of the Board of Directors of Fabino Life Sciences Limited is scheduled to be held on Wednesday, May 24, 2023 at Registered Office of the Company at 105, Plot No 12, Barodia Tower, 1st Floor, D Block, Central Market, Prashant Vihar, New Delhi- 110085, inter-alia to discuss and approve, among other items, the Audited Financial Results and Statement of Assets and Liabilities for Half Year and Financial Year ended March 31, 2023. Further, in terms of the Code of Conduct of Company adopted under SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in the securities of the Company is already closed and shall open 48 hours after conclusion of the Board Meeting.
17-05-2023
Next Page
Close

Let's Open Free Demat Account